| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2024-12-20 |
$1.68 |
0.0% |
397,964
|
$668,580 |
| Redmile Group, Llc |
Non-Executive Director |
Shattuck Labs, Inc. (STTK)
|
2024-12-04 |
$1.25 |
0.0% |
133,371
|
$166,714 |
| Redmile Group, Llc |
Non-Executive |
ADC Therapeutics SA (ADCT)
|
2024-07-01 |
$2.81 |
0.7% |
800,000
|
$2,248,000 |
| Redmile Group, Llc |
Non-Executive Director |
Absci Corp (ABSI)
|
2024-03-01 |
$4.50 |
-8.2% |
222,222
|
$999,999 |
| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2023-12-26 |
$3.72 |
-4.6% |
44,630
|
$166,024 |
| Redmile Group, Llc |
Non-Executive Director |
Augmedix, Inc. (AUGX)
|
2023-11-20 |
$4.00 |
-42.3% |
1,500,000
|
$6,000,000 |
| Redmile Group, Llc |
Non-Executive Director |
IGM Biosciences, Inc. (IGMS)
|
2023-06-29 |
$9.42 |
8.8% |
80,423
|
$757,585 |
| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2023-04-21 |
$6.17 |
-42.4% |
276,639
|
$1,705,829 |
| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2023-04-14 |
$6.00 |
-40.8% |
25,700
|
$154,200 |
| Redmile Group, Llc |
Non-Executive |
Entrada Therapeutics, Inc. (TRDA)
|
2021-11-02 |
$20.00 |
-23.0% |
1,000,000
|
$20,000,000 |
| Redmile Group, Llc |
Non-Executive Director |
Augmedix, Inc. (AUGX)
|
2021-10-28 |
$4.00 |
-42.3% |
1,625,000
|
$6,500,000 |
| Redmile Group, Llc |
Non-Executive |
Invivyd (IVVD)
|
2021-08-10 |
$17.00 |
-95.0% |
1,470,000
|
$24,990,000 |
| Redmile Group, Llc |
Non-Executive Director |
Absci Corp (ABSI)
|
2021-07-26 |
$16.00 |
-74.2% |
1,875,000
|
$30,000,000 |
| Redmile Group, Llc |
Non-Executive |
Verve Therapeutics, Inc. (VERV)
|
2021-06-21 |
$19.00 |
-70.9% |
1,050,000
|
$19,950,000 |
| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2021-01-08 |
$85.50 |
-95.8% |
327,485
|
$27,999,968 |
| Redmile Group, Llc |
Non-Executive Director |
Shattuck Labs, Inc. (STTK)
|
2020-10-14 |
$17.34 |
-79.6% |
3,441,176
|
$59,669,343 |
| Redmile Group, Llc |
Non-Executive Director |
IGM Biosciences, Inc. (IGMS)
|
2020-09-09 |
$50.52 |
-79.7% |
144,806
|
$7,316,025 |
| Redmile Group, Llc |
Non-Executive Director |
IGM Biosciences, Inc. (IGMS)
|
2020-09-03 |
$47.21 |
-78.3% |
136,649
|
$6,450,802 |
| Redmile Group, Llc |
Non-Executive Director |
FATE THERAPEUTICS INC (FATE)
|
2020-06-11 |
$28.31 |
-87.5% |
1,412,928
|
$39,999,992 |
| Redmile Group, Llc |
Non-Executive |
Neoleukin Therapeutics, Inc. (NLTX)
|
2020-04-02 |
$207.03 |
-93.3% |
9,715
|
$2,011,281 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-74.8% |
$-192,924,283 |
$257,754,339 |